Evidence map›Paper›PMID 41040660›Full record

ArticleFrontiers in genetics2025

BioSemAF-BiLSTM: a protein sequence feature extraction framework based on semantic and evolutionary information.

Zihan Zhang, Yixuan Wang

Abstract read
In one paragraph

Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zihan ZhangHaide College, Ocean University of China, Qingdao, China.
Yixuan WangSchool of Medicine, Nankai University, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

S-sulfenylation is a critical post-translational modification that plays an important role in regulating protein function, redox signaling, and maintaining cellular homeostasis. Accurate identification of S-sulfenylation sites is essential for understanding its biological significance and relevance to disease. However, the exclusive detection of S-sulfenylation sites through experimental methods remains challenging, as these approaches are often time-consuming and costly. Motivated by this issue, the present work proposed a deep learning-based computational framework, named BioSemAF-BiLSTM, which integrated evolutionary and semantic features to improve the prediction performance of S-sulfenylation sites. The framework employed fastText to generate subword-based sequence embeddings that captured local contextual information, and employed position-specific scoring matrices (PSSMs) to extract evolutionary conservation features. Importantly, we also quantitatively evaluated feature sufficiency at the protein sequence level using a sequence compression-based measure approximating Kolmogorov complexity, revealing an 11% information loss rate in predictive modeling using these features. These representations were subsequently fed into a bidirectional long short-term memory (BiLSTM) network to model long-range dependencies, and were further refined via an adaptive feature fusion module to enhance feature interaction. Experimental results on a benchmark dataset demonstrated that the model significantly outperformed conventional machine learning methods and current state-of-the-art deep learning approaches, achieving an accuracy of 89.32% on an independent test. It demonstrated improved sensitivity and specificity, effectively bridging the gap between bioinformatics and deep learning, and offered a robust computational tool for predicting post-translational modification sites.

Indexed as

adaptive fusionbidirectional LSTM neural networkbioinformation encodinginformation lossKolmogorov complexitypost-translational modificationprotein sequence embeddingsulfenylation site

Identifiers

PMID41040660
PMCPMC12483914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.